Display options
Cite
Al-Kathiri L, Mercyamma V, Al-Najjar T. A Case of Toxic Epidermal Necrolysis Successfully Treated with Low Dose Intravenous Immunoglobulins and Systemic Corticosteroid. Oman Med J. 2018;33(4):356-359doi: 10.5001/omj.2018.65.
Al-Kathiri, L., Mercyamma, V., & Al-Najjar, T. (2018). A Case of Toxic Epidermal Necrolysis Successfully Treated with Low Dose Intravenous Immunoglobulins and Systemic Corticosteroid. Oman medical journal, 33(4), 356-359. https://doi.org/10.5001/omj.2018.65
Al-Kathiri, Lutfi, et al. "A Case of Toxic Epidermal Necrolysis Successfully Treated with Low Dose Intravenous Immunoglobulins and Systemic Corticosteroid." Oman medical journal vol. 33,4 (2018): 356-359. doi: https://doi.org/10.5001/omj.2018.65
Al-Kathiri L, Mercyamma V, Al-Najjar T. A Case of Toxic Epidermal Necrolysis Successfully Treated with Low Dose Intravenous Immunoglobulins and Systemic Corticosteroid. Oman Med J. 2018 Jul;33(4):356-359. doi: 10.5001/omj.2018.65. PMID: 30038738; PMCID: PMC6047178.
Copy Download .nbib Format: NLM
Share it on

Oman Med J. 2018 Jul;33(4):356-359. doi: 10.5001/omj.2018.65.

A Case of Toxic Epidermal Necrolysis Successfully Treated with Low Dose Intravenous Immunoglobulins and Systemic Corticosteroid.

Oman medical journal

Lutfi Al-Kathiri, Varghese Mercyamma, Tasneem Al-Najjar

Affiliations

  1. Department of Dermatology, Sultan Qaboos Hospital, Salalah, Oman.

PMID: 30038738 PMCID: PMC6047178 DOI: 10.5001/omj.2018.65

Abstract

Toxic epidermal necrolysis (TEN), a severe form of Stevens-Johnson syndrome, is an acute life-threatening adverse drug reaction with a mortality rate of approximately 30%. Primary treatment of TEN is usually supportive. The use of intravenous immunoglobulin (IVIG) and corticosteroids are still uncertain, as there are only a limited number of studies comparing the usefulness of these treatments. We report a case of a Filipino male patient who developed TEN, most likely due to one of the medications he received during his course of illness. The patient was admitted to Sultan Qaboos Hospital, Salalah, with fever and diffuse painful maculopapular eruption, which became vesicular and bullous after few days, followed by shedding of large sheets of the epidermis. The patient was admitted initially under medical care, and a diagnosis of TEN was considered later. All unnecessary drugs were discontinued, and the patient was shifted to the burns unit. In addition to standard supportive treatment, a combination therapy of systemic steroid and a low-dose IVIG (1.2 g/kg) divided over three days was administered. This low-dose regimen of IVIG has a pharmacoeconomic benefit compared with the previous cumulative dose (3 g/kg), which is usually given by dermatologists in other institutions to patients with TEN. The outcome was excellent, and the condition recovered almost completely two weeks after starting the treatment without sequelae.

Keywords: Drug Eruptions; Drug-Related Side Effects and Adverse Reactions; Immunoglobulins, Intravenous; Stevens-Johnson Syndrome

References

  1. Indian J Dermatol Venereol Leprol. 2005 Nov-Dec;71(6):398-400 - PubMed
  2. Ann Surg. 1986 Nov;204(5):503-12 - PubMed
  3. Arch Dermatol. 2000 Mar;136(3):323-7 - PubMed
  4. Autoimmun Rev. 2008 Sep;7(8):598-605 - PubMed
  5. J Am Acad Dermatol. 2002 Oct;47(4):548-52 - PubMed
  6. Oman Med J. 2008 Apr;23(2):118-9 - PubMed
  7. J Am Acad Dermatol. 2007 Jan;56(1):e1-54 - PubMed
  8. J Burn Care Rehabil. 2004 Jan-Feb;25(1):81-8 - PubMed
  9. Indian J Dermatol Venereol Leprol. 2013 Jul-Aug;79(4):506-11 - PubMed
  10. J Am Coll Surg. 1995 Mar;180(3):340-2 - PubMed
  11. J Am Acad Dermatol. 2008 Jan;58(1):33-40 - PubMed
  12. Br J Dermatol. 2012 Aug;167(2):424-32 - PubMed
  13. Br J Dermatol. 1996 Apr;134(4):710-4 - PubMed
  14. Arch Dermatol. 2003 Jan;139(1):33-6 - PubMed
  15. Int J Dermatol. 2004 Nov;43(11):847-51 - PubMed
  16. J Invest Dermatol. 2008 Jan;128(1):35-44 - PubMed
  17. J Coll Physicians Surg Pak. 2010 Mar;20(3):205-7 - PubMed
  18. Plast Reconstr Surg. 1998 Sep;102(4):1018-22 - PubMed
  19. PLoS One. 2016 Nov 30;11(11):e0167120 - PubMed
  20. JAMA. 1987 Apr 24;257(16):2171-5 - PubMed
  21. J Am Acad Dermatol. 2007 Feb;56(2):181-200 - PubMed
  22. J Burn Care Rehabil. 2002 Mar-Apr;23(2):87-96 - PubMed

Publication Types